Skip to main content
CELLULAR GOODS PLC logo

CELLULAR GOODS PLC — Investor Relations & Filings

Ticker · CBX ISIN · GB00BK964W87 LEI · 213800IXPX4Z2MKX2U28 IL Manufacturing
Open in API
Filings indexed 232 across all filing types
Latest filing 2021-11-08 Regulatory Filings
Country GB United Kingdom
Listing IL CBX

About CELLULAR GOODS PLC

https://cellular-goods.com/

Cellular Goods PLC is a wellness company focused on developing consumer products using lab-grown, biosynthetic cannabinoids. The company's initial product lines included high-end skincare and topical athletic recovery solutions, utilizing cannabinoids like Cannabidiol (CBD) produced via cellular agriculture. This method aims to provide high-purity and sustainable ingredients. In early 2024, the company announced a strategic shift to focus on artificial intelligence applications within the beauty sector, leading to a proposed name change to Cel AI PLC.

Recent filings

Filing Released Lang Actions
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number : 6898R' and mentions 'This information is provided by RNS, the news service of the London Stock Exchange.' RNS stands for Regulatory News Service, which is a general regulatory announcement mechanism in the UK. The content itself is a brief notification regarding a 'Price Monitoring Extension' for a security, which is a specific, non-standard regulatory event update. Since it is a general regulatory announcement that doesn't fit into the more specific categories like DIV, DIRS, or ER, the most appropriate classification is the general regulatory filing category.
2021-11-08 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number : 6644R' and contains standard boilerplate language from RNS, the news service of the London Stock Exchange. The content itself is a very short announcement regarding a 'Second Price Monitoring Extension' for a security, which is a specific type of market operational notice. Since this is a general regulatory announcement that doesn't fit into the specific categories like ER, 10-K, or DIV, and it originates from the RNS system, the most appropriate classification is the general regulatory filing category.
2021-11-08 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number : 6613R' and mentions 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content itself is a brief announcement regarding a 'Price Monitoring Extension' for a security, which is a type of market operational update. This type of short, specific regulatory notification that doesn't fit into the major financial report categories (like 10-K, ER, IR) is best classified under the general regulatory announcement category, RNS. Given the short length (1919 chars) and the nature of the announcement (not a full report), RNS is the most appropriate code.
2021-11-08 English
Grant of Share Options and update on warrants
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number' header and explicitly states 'This information is provided by RNS, the news service of the London Stock Exchange.' The content details the 'Grant of Share Options' and an 'update on warrants' involving directors and executives, which relates to insider transactions and management compensation/incentives. However, the primary nature of the announcement is a regulatory disclosure of insider transactions (granting options to directors) and changes to previously announced warrant plans. This fits best under 'Director's Dealing' (DIRS) as it concerns executive share incentives, or potentially 'Regulatory Filings' (RNS) as a general disclosure. Since the core subject is the granting of options to management/directors, DIRS is more specific than the general RNS fallback. The document is a direct announcement, not a report about a report, so RPA is not applicable. Given the focus on options granted to managerial personnel, DIRS is the most appropriate classification.
2021-11-01 English
Second Price Monitoring Extn
Transaction in Own Shares Classification · 99% confidence The document is very short (1935 characters) and contains the header 'RNS Number : 8854N' and mentions 'RNS, the news service of the London Stock Exchange'. The content describes a 'Second Price Monitoring Extension' for a security, which is a specific, short-form market operational announcement. This type of brief, immediate market notification that does not fit into standard financial reporting categories (like 10-K, ER, or IR) is best classified under the general regulatory announcement category, RNS, as it is explicitly distributed via the RNS system.
2021-10-04 English
Price Monitoring Extension
Regulatory Filings Classification · 98% confidence The document explicitly starts with 'RNS Number' and mentions 'RNS, the news service of the London Stock Exchange' and 'Financial Conduct Authority'. The content describes a 'Price Monitoring Extension' for a security, which is a specific, short operational announcement related to trading mechanisms. Given its brevity (1918 chars) and its nature as a general regulatory notification disseminated via the RNS system, it fits best under the general regulatory announcement category, as it is not a specific financial report (like 10-K, ER, IR) or a specific corporate action (like DIV, DIRS, MANG). Therefore, the most appropriate classification is Regulatory Filings (RNS).
2021-10-04 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.